Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Macquarie Group Limited ( (AU:MQG) ).
Macquarie Group Limited has become a substantial holder in Australian Clinical Labs Limited, acquiring a significant voting power of 5.05%. This move highlights Macquarie’s strategic investment interests and its influence in the financial market, potentially impacting stakeholders and the company’s market positioning.
The most recent analyst rating on (AU:MQG) stock is a Hold with a A$200.00 price target. To see the full list of analyst forecasts on Macquarie Group Limited stock, see the AU:MQG Stock Forecast page.
More about Macquarie Group Limited
Macquarie Group Limited is a global financial services group providing a diverse range of services including asset management, banking, advisory, risk and capital solutions across debt, equity, and commodities. The company operates in various sectors, focusing on delivering innovative solutions to clients worldwide.
Average Trading Volume: 919,163
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$76.35B
Learn more about MQG stock on TipRanks’ Stock Analysis page.